vs
Side-by-side financial comparison of Criteo S.A. (CRTO) and Natera, Inc. (NTRA). Click either name above to swap in a different company.
Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $482.7M, roughly 1.4× Criteo S.A.). Natera, Inc. runs the higher net margin — 7.1% vs 4.4%, a 2.7% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 2.4%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $-36.6M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 1.4%).
Criteo S.A. is an advertising company that provides online display advertisements. The company was founded and is headquartered in Paris, France.
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
CRTO vs NTRA — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $482.7M | $665.5M |
| Net Profit | $21.3M | $47.3M |
| Gross Margin | 53.6% | — |
| Operating Margin | 6.3% | -3.4% |
| Net Margin | 4.4% | 7.1% |
| Revenue YoY | 2.4% | 39.8% |
| Net Profit YoY | -21.3% | 187.9% |
| EPS (diluted) | $0.39 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $665.5M | ||
| Q3 25 | — | $592.2M | ||
| Q2 25 | $482.7M | $546.6M | ||
| Q1 25 | $451.4M | $501.8M | ||
| Q4 24 | $553.0M | $476.1M | ||
| Q3 24 | $458.9M | $439.8M | ||
| Q2 24 | $471.3M | $413.4M | ||
| Q1 24 | $450.1M | $367.7M |
| Q4 25 | — | $47.3M | ||
| Q3 25 | — | $-87.5M | ||
| Q2 25 | $21.3M | $-100.9M | ||
| Q1 25 | $37.9M | $-66.9M | ||
| Q4 24 | $71.1M | $-53.8M | ||
| Q3 24 | $6.2M | $-31.6M | ||
| Q2 24 | $27.0M | $-37.5M | ||
| Q1 24 | $7.2M | $-67.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 53.6% | — | ||
| Q1 25 | 52.5% | — | ||
| Q4 24 | 54.4% | — | ||
| Q3 24 | 50.5% | — | ||
| Q2 24 | 49.4% | — | ||
| Q1 24 | 48.3% | — |
| Q4 25 | — | -3.4% | ||
| Q3 25 | — | -16.5% | ||
| Q2 25 | 6.3% | -20.2% | ||
| Q1 25 | 10.7% | -15.8% | ||
| Q4 24 | 17.1% | -13.6% | ||
| Q3 24 | 2.1% | -8.9% | ||
| Q2 24 | 7.8% | -10.6% | ||
| Q1 24 | 2.3% | -20.2% |
| Q4 25 | — | 7.1% | ||
| Q3 25 | — | -14.8% | ||
| Q2 25 | 4.4% | -18.5% | ||
| Q1 25 | 8.4% | -13.3% | ||
| Q4 24 | 12.9% | -11.3% | ||
| Q3 24 | 1.4% | -7.2% | ||
| Q2 24 | 5.7% | -9.1% | ||
| Q1 24 | 1.6% | -18.4% |
| Q4 25 | — | $0.36 | ||
| Q3 25 | — | $-0.64 | ||
| Q2 25 | $0.39 | $-0.74 | ||
| Q1 25 | $0.66 | $-0.50 | ||
| Q4 24 | $1.21 | $-0.41 | ||
| Q3 24 | $0.11 | $-0.26 | ||
| Q2 24 | $0.46 | $-0.30 | ||
| Q1 24 | $0.12 | $-0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $223.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $1.7B |
| Total Assets | $2.1B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | $223.6M | $16.0M | ||
| Q1 25 | $313.2M | $17.8M | ||
| Q4 24 | $316.9M | $22.7M | ||
| Q3 24 | $231.8M | $29.5M | ||
| Q2 24 | $233.2M | $90.3M | ||
| Q1 24 | $278.1M | $69.1M |
| Q4 25 | — | $1.7B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.0B | $1.2B | ||
| Q3 24 | $1.1B | $878.5M | ||
| Q2 24 | $1.0B | $836.5M | ||
| Q1 24 | $1.0B | $794.1M |
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | $2.1B | $1.8B | ||
| Q1 25 | $2.1B | $1.7B | ||
| Q4 24 | $2.3B | $1.7B | ||
| Q3 24 | $2.2B | $1.6B | ||
| Q2 24 | $2.2B | $1.5B | ||
| Q1 24 | $2.2B | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $73.9M |
| Free Cash FlowOCF − Capex | $-36.6M | $37.8M |
| FCF MarginFCF / Revenue | -7.6% | 5.7% |
| Capex IntensityCapex / Revenue | 7.3% | 5.4% |
| Cash ConversionOCF / Net Profit | -0.07× | 1.56× |
| TTM Free Cash FlowTrailing 4 quarters | — | $109.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $73.9M | ||
| Q3 25 | — | $59.4M | ||
| Q2 25 | $-1.4M | $37.6M | ||
| Q1 25 | $62.3M | $44.5M | ||
| Q4 24 | $169.5M | $52.9M | ||
| Q3 24 | $57.5M | $51.8M | ||
| Q2 24 | $17.2M | $4.0M | ||
| Q1 24 | $14.0M | $27.0M |
| Q4 25 | — | $37.8M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | $-36.6M | $11.7M | ||
| Q1 25 | $45.3M | $22.6M | ||
| Q4 24 | — | $34.8M | ||
| Q3 24 | — | $35.5M | ||
| Q2 24 | $-4.0M | $-7.7M | ||
| Q1 24 | $173.0K | $6.7M |
| Q4 25 | — | 5.7% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | -7.6% | 2.1% | ||
| Q1 25 | 10.0% | 4.5% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | -0.9% | -1.9% | ||
| Q1 24 | 0.0% | 1.8% |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | 7.3% | 4.7% | ||
| Q1 25 | 3.8% | 4.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | 4.5% | 2.8% | ||
| Q1 24 | 3.1% | 5.5% |
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.07× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 9.21× | — | ||
| Q2 24 | 0.64× | — | ||
| Q1 24 | 1.93× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRTO
| Commerce Growth | $393.9M | 82% |
| Retail Media | $60.9M | 13% |
| Other | $27.9M | 6% |
NTRA
Segment breakdown not available.